Lainesse C, Frank D, Beaudry F, Doucet M
Département de Biomédecine Vétérinaire, Faculté de Médecine Vétérinaire, Université de Montréal, St-Hyacinthe, QC, Canada.
J Vet Pharmacol Ther. 2007 Apr;30(2):116-26. doi: 10.1111/j.1365-2885.2007.00826.x.
This study was conducted to confirm an interindividual variability in pharmacokinetic parameters of clomipramine in a large population of cats and to identify potential covariables that would explain the presence of such pharmacokinetic variability after a single dose of Clomicalm. Clomipramine hydrochloride was administered orally according to a weight-dose chart from 0.32 to 0.61 mg/kg, to 76 cats and five blood samples were then taken by direct venipuncture at 1, 3, 6, 12, and 24 h. Plasma concentrations of clomipramine and desmethylclomipramine (DCMP) were measured by LC-MS/MS. The Standard Two-Stage technique was used to assess differences and detect correlations between pharmacokinetic parameter estimates and individual covariables. A large interindividual variability in all pharmacokinetic parameters (CV% 64-124) was detected. Statistically significant gender-related differences were detected in MR and Cl/F, where female cats had a higher mean MR (0.53) and faster Cl/F (0.36 L/h.kg) than males (0.36 and 0.21 L/h.kg, respectively). No correlation could be found between clomipramine AUC0-24 h or DCMP AUC0-24 h and sedation scores. Further feline studies are required to assess these findings after multiple dosing of clomipramine and DCMP to allow clinical extrapolation.
本研究旨在确认一大群猫中氯米帕明药代动力学参数的个体间变异性,并确定可能解释单次服用氯米帕明后药代动力学变异性存在的潜在协变量。根据0.32至0.61 mg/kg的体重剂量表,对76只猫口服盐酸氯米帕明,然后通过直接静脉穿刺在1、3、6、12和24小时采集五份血样。采用液相色谱-串联质谱法测定氯米帕明和去甲氯米帕明(DCMP)的血浆浓度。使用标准两阶段技术评估药代动力学参数估计值与个体协变量之间的差异并检测相关性。检测到所有药代动力学参数均存在较大的个体间变异性(CV% 64-124)。在代谢率(MR)和清除率/体重(Cl/F)方面检测到与性别相关的统计学显著差异,其中雌性猫的平均MR(0.53)较高,Cl/F(0.36 L/h.kg)比雄性猫(分别为0.36和0.21 L/h.kg)更快。氯米帕明的AUC0-24 h或DCMP的AUC0-24 h与镇静评分之间未发现相关性。需要进一步的猫类研究来评估多次服用氯米帕明和DCMP后的这些发现,以便进行临床推断。